MapLight Therapeutics, Inc. (MPLT)

Last Closing Price: 6.65 (2026-11-18)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

MapLight Therapeutics, Inc. (MPLT) had Net Income of $-51.62M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
Net Income
$-51.62M
--
--
$55.34M
$-55.34M
$3.73M
$-51.62M
$-51.62M
$-51.62M
$-51.62M
$-51.62M
$-51.62M
$-55.34M
$-55.35M
53.10M
53.10M
$-0.97
$-0.97
Balance Sheet Financials
$294.60M
$0.72M
$182.59M
$477.18M
$30.90M
--
$0.51M
$31.41M
$445.77M
$445.77M
$445.77M
55.67M
Cash Flow Statement Financials
$-131.72M
$-2.36M
$143.79M
$46.94M
$56.64M
$9.71M
$28.52M
--
--
Fundamental Metrics & Ratios
9.53
--
--
--
--
--
--
--
--
--
--
$-131.78M
--
--
--
--
--
--
--
-11.58%
-11.58%
-10.82%
-11.58%
$8.01
$-2.48
$-2.48